LeadCare Testing Systems (with Blood Obtained from a Vein) by Magellan Diagnostics: FDA Safety Communication - Risk of Inaccura
Date of publication: 25-05-2017
UPDATED 05/25/2017. Class I recall issued for LeadCare Plus and Ultra Testing Systems. Falsely lower test results may lead to improper patient management and treatment for lead exposure or poisoning. Źródło: https://www.fda.gov
